NasdaqCM:SGLB

Stock Analysis Report

Executive Summary

Sigma Labs, Inc. develops and commercializes manufacturing and materials technologies.

Snowflake

Fundamentals

Mediocre balance sheet with limited growth.

Share Price & News

How has Sigma Labs's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4.7%

SGLB

-0.2%

US Aerospace & Defense

1.8%

US Market


1 Year Return

-44.8%

SGLB

8.1%

US Aerospace & Defense

7.3%

US Market

Return vs Industry: SGLB underperformed the US Aerospace & Defense industry which returned 8.1% over the past year.

Return vs Market: SGLB underperformed the US Market which returned 7.3% over the past year.


Shareholder returns

SGLBIndustryMarket
7 Day4.7%-0.2%1.8%
30 Day-12.2%-3.2%-0.7%
90 Day-43.4%3.7%0.06%
1 Year-44.8%-44.8%10.2%8.1%9.7%7.3%
3 Year-86.0%-86.0%60.7%52.0%46.3%36.9%
5 Year-96.6%-96.6%95.5%77.1%64.5%46.5%

Price Volatility Vs. Market

How volatile is Sigma Labs's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Sigma Labs undervalued compared to its fair value and its price relative to the market?

5.39x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate SGLB's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate SGLB's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SGLB is unprofitable, so we can't compare its PE Ratio to the Aerospace & Defense industry average.

PE vs Market: SGLB is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate SGLB's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SGLB is overvalued based on its PB Ratio (5.4x) compared to the US Aerospace & Defense industry average (2.4x).


Next Steps

Future Growth

How is Sigma Labs forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

20.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SGLB is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SGLB is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SGLB is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SGLB's revenue (80% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: SGLB's revenue (80% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if SGLB's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Sigma Labs performed over the past 5 years?

-23.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: SGLB is unprofitable, and losses have increased over the past 5 years at a rate of -23% per year.

Accelerating Growth: Unable to compare SGLB's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SGLB is unprofitable, making it difficult to compare its past year earnings growth to the Aerospace & Defense industry (12.2%).


Return on Equity

High ROE: SGLB has a negative Return on Equity (-434.48%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: SGLB is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: SGLB is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Sigma Labs's financial position?


Financial Position Analysis

Short Term Liabilities: SGLB's short term assets ($1.5M) exceeds its short term liabilities ($768.0K)

Long Term Liabilities: SGLB has no long term liabilities


Debt to Equity History and Analysis

Debt Level: SGLB's debt to equity ratio (3.6%) is considered satisfactory

Reducing Debt: Insufficient data to determine if SGLB's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: SGLB has a high level of physical assets or inventory.

Debt Coverage by Assets: SGLB's debt is covered by short term assets (assets are 29.067820x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SGLB has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: SGLB has less than a year of cash runway if free cash flow continues to reduce at historical rates of -36.8% each year


Next Steps

Dividend

What is Sigma Labs's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.7%industryaverage1.8%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate SGLB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate SGLB's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if SGLB's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SGLB's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SGLB's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Sigma Labs's salary, the management and board of directors tenure and is there insider trading?

1.6yrs

Average management tenure


CEO

John Rice (73yo)

2.3yrs

Tenure

US$406,242

Compensation

Mr. John Reynolds Rice serves as the Chief Executive Officer of Sigma Labs, Inc. and has been its Chairman since April 19, 2017. Mr. Rice has been a President of Sigma Labs, Inc. since October 10, 2018 and ...


CEO Compensation Analysis

Compensation vs. Market: John has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.

Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

1.6yrs

Average Tenure

54yo

Average Age

Experienced Management: SGLB's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Age and Tenure

2.2yrs

Average Tenure

73.5yo

Average Age

Experienced Board: SGLB's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: SGLB insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$348,74622 Aug 19
Carl Schwartz
EntityIndividual
Shares500,000
Max PriceUS$0.75
BuyUS$560,00024 May 19
Carl Schwartz
EntityIndividual
Shares400,000
Max PriceUS$1.40

Ownership Breakdown


Management Team

  • Ronald Fisher (49yo)

    Vice President of Business Development

    • Tenure: 4.2yrs
    • Compensation: US$215.08k
  • John Rice (73yo)

    Chairman

    • Tenure: 2.3yrs
    • Compensation: US$406.24k
  • Darren beckett (45yo)

    Chief Technology Officer

    • Tenure: 1yrs
    • Compensation: US$190.02k
  • Frank Orzechowski (59yo)

    CFO, Treasurer

    • Tenure: 0.3yrs

Board Members

  • Kent Summers (61yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$132.54k
  • Dennis Duitch (74yo)

    Director

    • Tenure: 2.2yrs
    • Compensation: US$96.07k
  • Frank Garofalo (68yo)

    Director

    • Tenure: 2.8yrs
    • Compensation: US$54.00k
  • Chuck Farrar

    Member of Technical Advisory Board

    • Tenure: 0yrs
  • Vivek Dave (49yo)

    Member of Scientific & Technology Advisory Board

    • Tenure: 0.8yrs
    • Compensation: US$46.33k
  • Damon Giovanielli (75yo)

    Member of Technical Advisory Board

    • Tenure: 0yrs
  • Allen Mason (86yo)

    Member of Technical Advisory Board

    • Tenure: 0yrs
  • Jim Williams

    Member of Technical Advisory Board

    • Tenure: 0yrs
  • John Rice (73yo)

    Chairman

    • Tenure: 2.3yrs
    • Compensation: US$406.24k
  • Salvatore Battinelli (76yo)

    Director

    • Tenure: 2.2yrs
    • Compensation: US$91.07k

Company Information

Sigma Labs, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sigma Labs, Inc.
  • Ticker: SGLB
  • Exchange: NasdaqCM
  • Founded: 2010
  • Industry: Aerospace and Defense
  • Sector: Capital Goods
  • Market Cap: US$9.689m
  • Shares outstanding: 13.81m
  • Website: https://www.sigmalabsinc.com

Number of Employees


Location

  • Sigma Labs, Inc.
  • 3900 Paseo del Sol
  • Santa Fe
  • New Mexico
  • 87507
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SGLBNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDSep 2010

Biography

Sigma Labs, Inc. develops and commercializes manufacturing and materials technologies. It offers PrintRite3D, an In-Process-Quality-Assurance (IQPA) suite of software applications primarily for 3D metal pr ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/19 00:15
End of Day Share Price2019/10/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.